Physician profile
Beverly A Byrd
NPI 1033167945
$569.34
in general payments reported to CMS, 2019-2025
14 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $79.22 · 2021: $17.41 · 2022: $42.56 · 2023: $46.60 · 2024: $62.67 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $82.53 | 2022-2025 | Myrbetriq, Veozah |
| Biogen, INC. | $80.41 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $72.48 | 2019-2020 | |
| Novo Nordisk INC | $61.70 | 2019-2020 | |
| Pfizer INC. | $61.65 | 2019-2021 | |
| Organon LLC | $35.43 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.41 | 2019 | |
| Mayne Pharma Commercial LLC | $27.96 | 2025 | |
| Merck Sharp & Dohme LLC | $27.74 | 2019-2020 | |
| Lsi Solutions INC | $27.23 | 2025 | Fornisee |
| Myovant Sciences INC. | $17.39 | 2022 | |
| Sage Therapeutics, LLC | $15.84 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.51 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Byrd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.